©2026 Fox News Network, LLC. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed. All market data delayed 20 minutes.
The last time I spoke about ALX Oncology (ALXO) it was with respect to a Seeking Alpha article entitled "ALX Oncology: On Right Track With Latest Interim Analysis Of Evorpacept". The hope was that the ...
The company expects to present full biomarker analysis from the Phase I/II evorpacept and zanidatamab trial at the ESMO Breast Conference in May 2026. Safety data from the ALX2004 dose escalation ...
– Data from ASPEN-06 trial highlights CD47 expression as a key predictive biomarker of greater response to evorpacept in HER2+ Gastric Cancer; updated data to be presented at a medical conference in ...
Two Los Angeles County residents face federal charges after they were arrested on suspicion of illegally exporting tens of millions of dollars’ worth of artificial intelligence microchips to China, ...
Advanced chips were restricted to China in 2022 for US national security Chinese nationals shipped them without required export licenses Nvidia says diverted products would have no support Aug 5 ...
GameSpot may receive revenue from affiliate and advertising partnerships for sharing this content and from purchases through links. Are you looking for a way to destroy anomalies in The Alters? These ...
A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...
SOUTH SAN FRANCISCO, Calif., Jan. 23, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology” or the “Company”) (Nasdaq: ALXO), a clinical-stage biotechnology company advancing therapies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results